Blueshift Asset Management, LLC Halozyme Therapeutics, Inc. Transaction History

Blueshift Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$31.82 - $40.75 $610,848 - $782,277	-19,197 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$38.47 - $46.42 $270,174 - $326,007	7,023 Added 57.69%	19,197 $781,000
Q2 2021 Aug 13, 2021	BUY	$38.84 - $51.31 $148,990 - $196,825	3,836 Added 46.01%	12,174 $553,000
Q1 2021 May 06, 2021	BUY	$39.51 - $51.45 $329,434 - $428,990	8,338 New	8,338 $348,000
Q1 2020 May 14, 2020	SELL	$13.9 - $21.83 $242,318 - $380,562	-17,433 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $260,274 - $340,466	17,433 New	17,433 $309,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.